DR. PHOTINI SINNIS, M.D.
Osteopathic Medicine at 25 St, New York, NY
License number
New York 181345
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
341 E 25Th St, New York, NY 10010
Phone
(212) 263-6818
(212) 263-8116 (Fax)
(212) 263-8116 (Fax)
Personal information
See more information about PHOTINI SINNIS at radaris.comName
Address
Phone
3 Washington Square Vlg APT 8C, New York, NY 10012
3 Washington Sq, New York, NY 10012
Organization information
See more information about PHOTINI SINNIS at bizstanding.comPhotini Sinnis MD
341 E 25 St, New York, NY 10010
Industry:
Internist
Phone:
(212) 263-6818 (Phone)
Photini Sinnis
Professional information
Associate Professor At Nyu School Of Medicine
Position:
Associate Professor at NYU School of Medicine
Location:
Greater New York City Area
Industry:
Hospital & Health Care
Work:
NYU School of Medicine
-
Associate Professor
Photini Sinnis, New York NY
Specialties:
Internal Medicine, Infectious Disease
Work:
NYU Hospitals Center
550 1St Ave, New York, NY 10016
550 1St Ave, New York, NY 10016
Education:
Dartmouth College (1988)
Dr. Photini Sinnis, New York NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
341 E 25Th St, New York 10010
(212) 263-6818 (Phone), (212) 263-8116 (Fax)
(212) 263-6818 (Phone), (212) 263-8116 (Fax)
Certifications:
Internal Medicine, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Dartmouth College
Graduated: 1988
Columbia-Presbyn Hosp
Dartmouth College
Graduated: 1988
Columbia-Presbyn Hosp
Associate Professor At Nyu School Of Medicine
Location:
Greater New York City Area
Industry:
Research
Compositions And Methods For Inhibiting Hepatocyte Invasion By Malarial Sporozoites
US Patent:
2003011, Jun 26, 2003
Filed:
Mar 14, 2002
Appl. No.:
10/098238
Inventors:
Carla Cerami - New York NY, US
Ute Frevert - New York NY, US
Photini Sinnis - New York NY, US
Victor Nussenzweig - New York NY, US
Ute Frevert - New York NY, US
Photini Sinnis - New York NY, US
Victor Nussenzweig - New York NY, US
Assignee:
New York University
International Classification:
A61K038/17, C07H021/04, C12N009/99, C12P021/02, C12N005/06
US Classification:
514/012000, 435/184000, 435/069200, 435/320100, 435/325000, 536/023200
Abstract:
There is provided peptide and mimetic inhibitors for the binding of a circumsporozoite polypeptide to receptors of hepatocytes from malaria-susceptible mammals. Also contemplated is a method of inhibiting the binding of a malaria sporozoites to hepatocytes susceptible to sporozoite invasion. A peptide of Region II+ of the circumsporozoite protein is also provided, as is a method of targeting the delivery of substances to hepatocytes.
Methods And Compositions For Malaria Prophylaxis
US Patent:
2011022, Sep 15, 2011
Filed:
Dec 10, 2010
Appl. No.:
12/965622
Inventors:
Photini Sinnis - New York NY, US
Alida Coppi - Flushing NY, US
Elizabeth Nardin - Leonia NJ, US
Alida Coppi - Flushing NY, US
Elizabeth Nardin - Leonia NJ, US
Assignee:
New York University - New York NY
International Classification:
A61K 39/395, A61P 33/06
US Classification:
4241721
Abstract:
A composition for preventing malaria infection including a steric inhibitor of circumsporozoite protein cleavage. A pharmaceutical composition for preventing malaria infection including a steric inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by sterically inhibiting circumsporozoite protein processing or by directly inhibiting a protease of a sporozoite from binding to its target. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing through steric or direct inhibition.
Methods And Compositions For Malaria Prophylaxis
US Patent:
2010011, May 6, 2010
Filed:
Sep 29, 2009
Appl. No.:
12/549520
Inventors:
Photini Sinnis - New York NY, US
Alida Coppi - Flushing NY, US
Alida Coppi - Flushing NY, US
International Classification:
A61K 31/105, A61P 33/06
US Classification:
514708
Abstract:
A composition for preventing malaria infection including a protease inhibitor. A pharmaceutical composition for preventing malaria infection including a protease inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by inhibiting circumsporozoite protein processing or by inhibiting a protease of a sporozoite. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing.
Methods And Compositions For Malaria Prophylaxis
US Patent:
2009009, Apr 9, 2009
Filed:
Oct 3, 2007
Appl. No.:
11/866738
Inventors:
Photini Sinnis - New York NY, US
Alida Coppi - Flushing NY, US
Elizabeth Nardin - Leonia NJ, US
Alida Coppi - Flushing NY, US
Elizabeth Nardin - Leonia NJ, US
International Classification:
A61K 39/395, C07K 16/00
US Classification:
4241411, 5303871, 5303881, 4241301
Abstract:
A composition for preventing malaria infection including a steric inhibitor of circumsporozoite protein cleavage. A pharmaceutical composition for preventing malaria infection including a steric inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by sterically inhibiting circumsporozoite protein processing or by directly inhibiting a protease of a sporozoite from binding to its target. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing through steric or direct inhibition.
Methods And Compositions For Malaria Prophylaxis
US Patent:
2006012, Jun 8, 2006
Filed:
Aug 10, 2005
Appl. No.:
11/200723
Inventors:
Photini Sinnis - New York NY, US
Alida Coppi - Flushing NY, US
Alida Coppi - Flushing NY, US
International Classification:
A61K 31/336
US Classification:
514475000
Abstract:
A composition for preventing malaria infection including a protease inhibitor. A pharmaceutical composition for preventing malaria infection including a protease inhibitor and a pharmaceutical carrier. A method of malaria infection prophylaxis including the step of administering an effective amount of the composition of the present invention. A method of malaria prophylaxis by inhibiting circumsporozoite protein processing or by inhibiting a protease of a sporozoite. Methods of preventing sporozoite cell invasion or preventing circumsporozoite processing.